IHE

iShares U.S. Pharmaceuticals ETF [IHE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

IHE Stock Summary

Top 10 Correlated ETFs

IHE

Top 10 Correlated Stocks

IHE

In the News

IHE Financial details

Company Rating
-
Market Cap
642.87M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.64
Dividend %
1.34%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
2.41%
SMA50
13.33%
SMA100
25%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
55.363335-69.56
52W High
+24.36%
52W Low
+56.01%
RSI
56
Rel Volume
0.84
Avg Volume
72.67K
Volume
60.93K
Perf Week
-0.2%
Perf Month
2.09%
Perf Quarter
27.82%
Perf Half Y
30.22%
-
-
-
-
Beta
0.57
-
-
Volatility
0.57%, 1.1%
Prev Close
1.41%
Price
85.805
Change
1.2%

IHE Financial Performance

IHE Dividend History

IHE Frequently Asked Questions

What is iShares U.S. Pharmaceuticals ETF stock symbol ?

iShares U.S. Pharmaceuticals ETF is a US stock and trading under the symbol IHE

What is iShares U.S. Pharmaceuticals ETF stock quote today ?

iShares U.S. Pharmaceuticals ETF stock price is $85.805 today.

Is iShares U.S. Pharmaceuticals ETF stock public?

Yes, iShares U.S. Pharmaceuticals ETF is a publicly traded company.

Something similar

Top by Market Cap
BRH.DE
ABEA.DE
MSF.DE
BRK-B
VTSAX
Top Correlated ETFs
PPH
FTXH
SELV
LDUR
PJP
Top Correlated Stocks
REGN
H
PRI
LLY
YUM
Similar Market Cap
E15H.DE
PNQI
BUFF
IQQX.DE
XAXD.L

Company Profile

Financial Services Asset Management
  • Volume Average 72.67K
  • Market Capitalization 642.87M
  • Headquarters US
  • IPO Date 2006-05-05

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.